Wells Fargo & Company Anika Therapeutics, Inc. Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 5,662 shares of ANIK stock, worth $96,593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,662
Previous 6,107
7.29%
Holding current value
$96,593
Previous $154,000
9.74%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ANIK
# of Institutions
124Shares Held
11.4MCall Options Held
200Put Options Held
100-
Trigran Investments, Inc.2.12MShares$36.2 Million5.75% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$27.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA799KShares$13.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX707KShares$12.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny574KShares$9.8 Million0.02% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $249M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...